Veröffentlichungen Suche Suche Autor/in Forschungsgruppe Veröffentlichungsdatum Wirkungsfaktor Suchen Sortieren nach RelevanceFrom A-ZAuthored onDate/Time RangeRelease date Reihenfolge AufsteigendAbsteigend Akalin, Altuna Dr. (1) Beule, Dieter Dr. (1) Birchmeier-Kohler, Carmen Prof. Dr. (2) Blankenstein, Thomas Prof. Dr. (1) Bogdanow, Boris (1) Bunse, Mario Dr. (1) Clauß, Julian (1) Costanza, Mariantonia (1) Daniel, Peter Prof. Dr. (1) Diecke, Sebastian Dr. (1) Gerhardt, Holger Prof. Dr. (1) Haucke, Volker Professor (1) Hinze, Christian Dr. med. Dipl.-Math. (1) Höpken, Uta Elisabeth PD Dr. (1) Ivics, Zoltan Dr. (1) Izsvak, Zsuzsanna Dr. (1) Kärgel, Eva Dr. (1) Kastelic, Nicolai (1) Kempa, Stefan Dr. (1) Kettenmann, Helmut Prof. Dr. (1) Kieback, Elisa Dr. (2) Kirchner, Marieluise Dr. (2) Kühn, Ralf Dr. (1) Kühnemund, Johannes (1) Landthaler, Markus Prof. Dr. (1) Leisegang, Matthias Dr. (1) Lewin, Gary Prof. Dr. (1) Mathas, Stephan Dr. (5) Milek, Miha Dr. (1) Rehm, Armin Dr. (1) Rudolph, Ina-Maria Dr. (1) Scheidereit, Claus Prof. Dr. (1) Sczakiel, Henrike (1) Selbach, Matthias Prof. Dr. (8) Szymborska-Mell, Anna Bozena Dr. (1) Uckert, Wolfgang Prof. Dr. (5) Uyar, Bora Dr. (1) Willnow, Thomas Prof. Dr. (1) Wolf, Susanne Dr. (1) Wollert-Wulf, Brigitte (2) Zauber, Henrik Dr. (3) (-) Janz, Martin Dr. (5) (-) Lusatis, Simone (1) (-) Biologie maligner Lymphome (5) Experimentelle Genetik von Herz- Kreislauferkrankungen (1) (-) Molekulare Zellbiologie und Gentherapie (1) Signaltransduktion in Tumorzellen (1) Systembiologie von Gen-regulatorischen Elementen (1) 2003 (3) 2004 (2) 2005 (2) (-) 2006 (4) 2007 (2) 2008 (2) 2009 (3) 2010 (1) 2011 (4) 2012 (2) 2013 (2) 2014 (2) 2015 (2) 2016 (1) 2017 (3) (-) 2018 (1) 2020 (4) 5 Ergebnisse: Active Filter: Janz, Martin Dr.Lusatis, SimoneBiologie maligner LymphomeMolekulare Zellbiologie und Gentherapie20062018 Sortieren: Treffgenauigkeit Neueste nach älteste Älteste nach neueste 01. September 2018 in Leukemia The AP-1-BATF and -BATF3 module is essential for growth, survival and TH17/ILC3 skewing of anaplastic large cell lymphoma N. Schleussner O. Merkel M. Costanza H.C. Liang F. Hummel C. Romagnani P. Durek I. Anagnostopoulos M. Hummel K. Jöhrens A. Niedobitek P.R. Griffin R. Piva H.L. Sczakiel W. Woessmann C. Damm-Welk C. Hinze D. Stoiber B. Gillissen S.D. Turner E. Kaergel L. von Hoff M. Grau G. Lenz B. Dörken C. Scheidereit L. Kenner M. Janz S. Mathas 15. Mai 2006 in Cell Cycle Reprogramming of B lymphoid cells in human lymphoma pathogenesis M. Janz B. Doerken S. Mathas 01. April 2006 in Cell Death Differ Loss of the tissue-specific proapoptotic BH3-only protein Nbk/Bik is a unifying feature of renal cell carcinoma I. Sturm C. Stephan B. Gillissen R. Siebert M. Janz S. Radetzki K. Jung S. Loening B. Doerken P.T. Daniel 15. März 2006 in Blood Classical Hodgkin lymphoma is characterized by high constitutive expression of activating transcription factor 3 (ATF3) which promotes viability of Hodgkin/Reed-Sternberg cells M. Janz M. Hummel M. Truss B. Wollert-Wulf S. Mathas K. Joehrens C. Hagemeier K. Bommert H. Stein B. Doerken R.C. Bargou 01. Februar 2006 in Nat Immunol Intrinsic inhibition of transcription factor E2A by HLH proteins ABF-1 and Id2 mediates reprogramming of neoplastic B cells in Hodgkin lymphoma S. Mathas M. Janz F. Hummel M. Hummel B. Wollert-Wulf S. Lusatis I. Anagnostopoulos A. Lietz M. Sigvardsson F. Jundt K. Joehrens K. Bommert H. Stein B. Doerken
01. September 2018 in Leukemia The AP-1-BATF and -BATF3 module is essential for growth, survival and TH17/ILC3 skewing of anaplastic large cell lymphoma N. Schleussner O. Merkel M. Costanza H.C. Liang F. Hummel C. Romagnani P. Durek I. Anagnostopoulos M. Hummel K. Jöhrens A. Niedobitek P.R. Griffin R. Piva H.L. Sczakiel W. Woessmann C. Damm-Welk C. Hinze D. Stoiber B. Gillissen S.D. Turner E. Kaergel L. von Hoff M. Grau G. Lenz B. Dörken C. Scheidereit L. Kenner M. Janz S. Mathas
15. Mai 2006 in Cell Cycle Reprogramming of B lymphoid cells in human lymphoma pathogenesis M. Janz B. Doerken S. Mathas
01. April 2006 in Cell Death Differ Loss of the tissue-specific proapoptotic BH3-only protein Nbk/Bik is a unifying feature of renal cell carcinoma I. Sturm C. Stephan B. Gillissen R. Siebert M. Janz S. Radetzki K. Jung S. Loening B. Doerken P.T. Daniel
15. März 2006 in Blood Classical Hodgkin lymphoma is characterized by high constitutive expression of activating transcription factor 3 (ATF3) which promotes viability of Hodgkin/Reed-Sternberg cells M. Janz M. Hummel M. Truss B. Wollert-Wulf S. Mathas K. Joehrens C. Hagemeier K. Bommert H. Stein B. Doerken R.C. Bargou
01. Februar 2006 in Nat Immunol Intrinsic inhibition of transcription factor E2A by HLH proteins ABF-1 and Id2 mediates reprogramming of neoplastic B cells in Hodgkin lymphoma S. Mathas M. Janz F. Hummel M. Hummel B. Wollert-Wulf S. Lusatis I. Anagnostopoulos A. Lietz M. Sigvardsson F. Jundt K. Joehrens K. Bommert H. Stein B. Doerken
